Intracranial Hemorrhage in Patients with Cancer Authors
Cardiovascular Disease and Stroke (M Fink and J Safdieh, Section Editors)
First Online: 21 April 2012 DOI:
Cite this article as: Velander, A.J., DeAngelis, L.M. & Navi, B.B. Curr Atheroscler Rep (2012) 14: 373. doi:10.1007/s11883-012-0250-3 Abstract
Intracranial hemorrhage (ICH) is a common neurological emergency in patients with cancer, typically occurring late in the disease course, although it occasionally heralds the cancer diagnosis. ICH in these patients often occurs from unique mechanisms, especially intratumoral hemorrhage or coagulopathy, whereas hypertensive hemorrhage is rare. Lung, melanoma, breast, and glioblastoma multiforme are the most commonly associated solid tumors, partly because of their ubiquity and frequent brain involvement, whereas leukemia is the most commonly associated hematological cancer. Patients typically present with focal neurological deficits, headache, and encephalopathy, and their initial diagnostic evaluation and management should follow standard guidelines, although steroids and/or surgical resection should be strongly considered in those with intratumoral hemorrhage. Short-term outcomes are comparable to ICH in the community, whereas long-term outcomes are generally poor, corresponding to the prognosis of the underlying cancer. This review focuses on the recent advances and special considerations in cancer-related intracranial hemorrhage.
Keywords Cancer Malignancy Neoplasm Intracranial hemorrhage Hemorrhagic stroke Intracerebral hemorrhage Subarachnoid hemorrhage References Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.
Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985;64:16–35.
McCormick WF, Rosenfield DB. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke. 1973;4:946–54.
Licata B, Turazzi S. Bleeding cerebral neoplasms with symptomatic hematoma. J Neurosurg Sci. 2003;47:201–10.
•• Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010;74:494–501.
This is a large modern series from the Memorial Sloan-Kettering Cancer Center of intracerebral and subarachnoid hemorrhage in patients with cancer (including systemic and primary brain neoplasms). This study details the demographics, presentation, pathophysiology, and outcome of patients with cancer and intracerebral and/or subarachnoid hemorrhage.
Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin. 2003;21:167–92.
Minette SE, Kimmel DW. Subdural hematoma in patients with systemic cancer. Mayo Clin Proc. 1989;64:637–42.
Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol. 2005;75:57–61.
Simmons NE, Elias WJ, Henson SL, Laws ER. Small cell lung carcinoma causing epidural hematoma: case report. Surg Neurol. 1999;51:56–69.
Navi BB, Segal AZ. Cancer and stroke. In: Geyer JD, Gomez CR, editors. Stroke: a practical approach. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 48–55.
Weisberg LA. Computerized tomography in intracranial hemorrhage. Arch Neurol. 1979;36:422–6.
• Kamel H, Navi BB, Hemphill JC. A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care. 2011;1–5.
This is a retrospective study of the yield of MRI for underlying lesions in patients with spontaneous intracerebral hemorrhage, suggesting that the yield can be stratified by clinical characteristics, such as age, history of hypertension, and a lobar location.
Kothbauer P, Jellinger K, Falment H. Primary brain tumour presenting as spontaneous intracerebral haemorrhage. Acta Neurochir (Wien). 1979;49:35–45.
Schrader B, Barth H, Lang EW, et al. Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien). 2000;142:979–85.
Abrahams NA, Prayson RA. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: a clinical pathologic analysis of 31 cases. Ann Diagn Pathol. 2000;4:361–6.
Scott M. Spontaneous intracerebral hematoma caused by cerebral neoplasms. Report of eight verified cases. J Neurosurg. 1975;42:338–42.
Jellinger K. Pathology of intracerebral hemorrhage. Zentralbl Neurochir. 1977;38:29–42.
Kondziolka D, Bernstein M, Resch L, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67:852–7.
Lieu AS, Hwang SL, Howng SL, Chai CY. Brain tumors with hemorrhage. J Formos Med Assoc. 1999;98:365–7.
van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.
Liu Y, Liu M, Zhu S, et al. Intracranial tumoural haemorrhage-a report of 58 cases. J Clin Neurosci. 2002;9:637–9.
Liwnicz BH, Wu SZ, Tew JM. The relationship between the capillary structure and hemorrhage in gliomas. J Neurosurg. 1987;66:536–41.
Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698–705.
Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865–72.
Chang L, Chen Y-LL, Kao M-CC. Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol. 2004;62:172–7.
Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.
Oka K, Tsuda H, Sakamoto S, Go Y, et al. Plasminogen activator and hemorrhage in brain tumors. J Neurooncol. 1994;22:183–7.
Shin J, Moon K-SS, Jung T-YY, et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76:257–63.
Wakai S, Yamakawa K, Manaka S, et al. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10:437–44.
Openshaw H, Ressler JA, Snyder DS. Lumbar puncture and subdural hygroma and hematomas in hematopoietic cell transplant patients. Bone Marrow Transplant. 2008;41:791–5.
McIver JI, Scheithauer BW, Rydberg CH, et al. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report. Neurosurgery. 2001;49:447–9.
Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257–62.
Atlas SW, Grossman RI, Gomori JM, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology. 1987;164:71–7.
Tung GA, Julius BD, Rogg JM. MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause. Neuroradiology. 2003;45:357–62.
Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
Brain Trauma Foundation. Guidelines for the surgical management of traumatic brain injury. Neurosurgery. 2006;58 Suppl 2.
Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322:494–500.
Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.
Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.
Golash A, Thorne J, West CG. Low grade pilocytic astrocytoma presenting as a spontaneous intracerebral haemorrhage in a child. Br J Neurosurg. 1998;12:59–62.
Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Report Med. 2011;1–3.
• Masrur S, Abdullah AR, Smith EE, et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis. 2011;20:124–130.
This is the largest clinical series (n
18) of thrombolytic therapy for acute ischemic stroke in patients with cancer. The rate of symptomatic intracranial hemorrhage in these patients was reasonable (5.6 %), suggesting that thrombolysis may be safe in patients with malignancy.
Graber JJ, Nayak L, DeAngelis LM. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. J Neurooncol. 2012;In press.
Schiff D, DeAngelis LM. Therapy of venous thromboembolism in patients with brain metastases. Cancer. 1994;73:493–8.
Nghiemphu PL, Green RM, Pope WB, et al. Safety of anticoagulation use and bevacizumab in patients with glioma. Neuro Oncol. 2008;10:355–60.
• Khasraw M, Holodny A, Goldlust SA, DeAngelis LM: Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Ann Oncol 2011.
This is a Retrospective analysis of 4191 patients with cancer who received bevacizumab at the Memorial Sloan-Kettering Cancer Center. In this study, intracranial hemorrhage in these patients was rare and prior bevacizumab therapy was not associated with an increased rate.
Novello S, Camps C, Grossi F, et al. Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases. J Thorac Oncol. 2011;6:1260–6.
Anderson WS, Moore LE, Ford E, Rigamonti D. Fatal case of intracerebral hemorrhage during gamma knife treatment for metastases. Clin Neurol Neurosurg. 2008;110:838–42.
PubMed CrossRef Copyright information
© Springer Science+Business Media, LLC 2012